MGMT and neoplasm: Loss of 1p and 19q and mutant IDH1 (Isocitrate Dehydrogenase 1) as well as O6-methylguanin-DNA-methyltransferase (MGMT) promoter methylation were detected in glioma patients, and efforts to locate these aberrations in circulating tumor cells are ongoing [76,77].